S. Corya

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Normal gut microbiota modulates brain development and behavior

Sexual Dysfunction, Depression, and the Impact of Antidepressants

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder

Depression

Augmentation of Antidepressants with Atypical Antipsychotics: A Review of the Current Literature

Major depressive disorder

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain

Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development

Network pharmacology: the next paradigm in drug discovery

Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis

What Happened to Lithium? Antidepressant Augmentation in Clinical Settings

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex

Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Antidepressant-like effects of N-acetyl-L-cysteine in rats

The Effect of Exercise Training on Anxiety Symptoms Among Patients

Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer

The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Prevalence and management of treatment-resistant depression.

What Happened to Lithium? Antidepressant Augmentation in Clinical Settings

Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

Therapeutic Options for Treatment-Resistant Depression

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression

Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination

Effect of comorbid anxiety on treatment response in bipolar depression

Olanzapine-fluoxetine combination in treatment-resistant depression